Wilford Hall Ambulatory Surgical Center

Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 9, 2023

The "Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The urokinase market is being driven by the increasing prevalence of pulmonary embolism (PE), a condition characterized by blood clots in the lungs.
  • Urokinase, a thrombolytic agent, is used to dissolve these clots and is naturally produced by the human body.
  • The urokinase market is highly competitive, featuring numerous players involved in developing and marketing urokinase products.

Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting

Retrieved on: 
Friday, November 3, 2023

The ASC extension will go into effect on January 1, 2024.

Key Points: 
  • The ASC extension will go into effect on January 1, 2024.
  • C9734 was one of 11 HCPCS C codes that were added to the ASC Covered Procedure List, out of the 235 procedure recommendations CMS received.
  • CMS determined that these 11 codes correspond to procedures that are frequently performed in outpatient settings and increasingly show lower risks of serious complications and inpatient admissions.
  • In the meantime, we are pleased that both U.S. hospitals and ASCs performing the TULSA procedure on Medicare patients will now be able to utilize the temporary C code, C9734.”

Cardiology Applications Drive Dominance in the Radiofrequency Ablation Devices Market, Fueled by Rising Cardiovascular Disease Prevalence - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 19, 2023

The increasing prevalence of chronic diseases, especially cardiovascular diseases and cancers, coupled with a growing elderly population and technological innovations in these devices, is fueling the demand for radiofrequency ablation devices.

Key Points: 
  • The increasing prevalence of chronic diseases, especially cardiovascular diseases and cancers, coupled with a growing elderly population and technological innovations in these devices, is fueling the demand for radiofrequency ablation devices.
  • Cardiovascular Diseases: A major cause of global mortality, driving the demand for radiofrequency ablation devices.
  • The escalating incidence of cardiovascular diseases is expected to drive the demand for radiofrequency ablation devices, especially in the treatment of atrial fibrillation.
  • Radiofrequency ablation devices are widely used in oncology and cardiology to treat conditions such as tumors and arrhythmias.

Bronchoscopy Market Soars to $3.9 Billion by 2028: Comprehensive Report Unveils Growth Potential - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 11, 2023

The global bronchoscopy market, valued at $2.5 billion in 2022, is projected to experience robust growth, reaching approximately $3.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 7.4%.

Key Points: 
  • The global bronchoscopy market, valued at $2.5 billion in 2022, is projected to experience robust growth, reaching approximately $3.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 7.4%.
  • This significant market expansion is detailed in a comprehensive report that delves into market dynamics, drivers, challenges, and growth opportunities.
  • An estimate of the actual market size and a revenue forecast for the global bronchoscopy market, with corresponding market share analysis.
  • The bronchoscopy market is witnessing significant growth due to the increasing prevalence of airway and lung diseases globally.

EyeSouth Partners Unveils Two Ambulatory Surgery Centers For Its Affiliates In Orlando and Chicago Areas

Retrieved on: 
Wednesday, October 11, 2023

EyeSouth Partners (“EyeSouth” or “the company”) is pleased to unveil its two latest surgery centers, Heathrow Surgery Center , and the EyeSouth Surgery Center at Oak Lawn, representing its first official Ambulatory Surgical Centers (ASC) in both the Greater Orlando and Greater Chicago areas.

Key Points: 
  • EyeSouth Partners (“EyeSouth” or “the company”) is pleased to unveil its two latest surgery centers, Heathrow Surgery Center , and the EyeSouth Surgery Center at Oak Lawn, representing its first official Ambulatory Surgical Centers (ASC) in both the Greater Orlando and Greater Chicago areas.
  • The new centers are its 19th and 20th ASCs in the EyeSouth network overall, both of which are CMS certified.
  • This includes 19 surgery centers strategically situated throughout Georgia, Texas, Louisiana, Florida, Tennessee, Ohio, Kentucky, Pennsylvania, Alabama, Illinois, North Carolina, and South Carolina.
  • To learn more about EyeSouth Partners and the shared services it offers its affiliates, visit www.eyesouthpartners.com or contact Chris O’Dekirk, VP of M&A and Business Development, [email protected] .

Global External Fixators Market Analysis Report 2023-2030 - Ambulatory Surgical Centers to Witness Significant Market Share - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 8, 2023

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space.

Key Points: 
  • The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space.
  • The Manual Fixators is projected to witness significant market share during forecast period.
  • Based on End User, the market is studied across Ambulatory Surgical Centers, Hospitals, and Orthopedic & Trauma Centers.
  • The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Global Tricuspid Valve Repair Market to Reach $1 Billion by 2030, Driven by Rising Cardiovascular Disease Incidence and Technological Advancements - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 26, 2023

The "Tricuspid Valve Repair Market Size, Share & Trends Analysis Report By End-use (Ambulatory Surgical Centers, Hospitals), By Indication (Tricuspid Valve Regurgitation, Tricuspid Valve Stenosis), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Tricuspid Valve Repair Market Size, Share & Trends Analysis Report By End-use (Ambulatory Surgical Centers, Hospitals), By Indication (Tricuspid Valve Regurgitation, Tricuspid Valve Stenosis), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global tricuspid valve repair market size is expected to reach USD 1.0 billion by 2030.
  • The main causes of tricuspid are bacterial infection, Ebstein's anomaly, connective tissue problems, carcinoid tumors, myxomatous degeneration, and other cardiac disorders or ailments, which cause pulmonary hypertension.
  • Annuloplasty rings are placed during tricuspid valve repair surgeries to improve long-term outcomes.

Dataintelo releases comprehensive Global Mobile C-arm Systems Market report providing valuable insights and growth factors

Retrieved on: 
Wednesday, June 21, 2023

This research report is a comprehensive analysis of the market trends, growth factors, and opportunities in the mobile C-arm systems industry.

Key Points: 
  • This research report is a comprehensive analysis of the market trends, growth factors, and opportunities in the mobile C-arm systems industry.
  • The Global Mobile C-arm Systems Market report is a meticulously crafted document that offers a detailed analysis of the market based on type, application, end user, and region.
  • One of the standout features of the report is its focus on the growth factors driving the global mobile C-arm systems market.
  • The Global Mobile C-arm Systems Market report by Dataintelo is a valuable resource for anyone interested in the market dynamics, trends, and growth factors.

Dataintelo releases comprehensive Global Mobile C-arm Systems Market report providing valuable insights and growth factors

Retrieved on: 
Wednesday, June 21, 2023

This research report is a comprehensive analysis of the market trends, growth factors, and opportunities in the mobile C-arm systems industry.

Key Points: 
  • This research report is a comprehensive analysis of the market trends, growth factors, and opportunities in the mobile C-arm systems industry.
  • The Global Mobile C-arm Systems Market report is a meticulously crafted document that offers a detailed analysis of the market based on type, application, end user, and region.
  • One of the standout features of the report is its focus on the growth factors driving the global mobile C-arm systems market.
  • The Global Mobile C-arm Systems Market report by Dataintelo is a valuable resource for anyone interested in the market dynamics, trends, and growth factors.

Jim Sheets Named Group President for Multi-State Health System Based in Colorado

Retrieved on: 
Wednesday, May 31, 2023

(Centennial, Colo.), May 31, 2023 (GLOBE NEWSWIRE) -- Centura Health, the health care leader in Colorado, Utah and southwest Kansas, is pleased to announce that Jim Sheets has been named Group President, effective June 5, 2023.

Key Points: 
  • (Centennial, Colo.), May 31, 2023 (GLOBE NEWSWIRE) -- Centura Health, the health care leader in Colorado, Utah and southwest Kansas, is pleased to announce that Jim Sheets has been named Group President, effective June 5, 2023.
  • On a mission to elevate others through service, authentic engagement, and fun, Jim will be responsible for the CommonSpirit Health hospitals and clinics in Denver, Fort Morgan, Colo., and Utah.
  • He will also have responsibility for the health system’s continued growth in Denver and Utah.
  • Jim has served in progressive leadership roles with Intermountain Healthcare for 16 years.